Process Characterization (PC) and Process Validation (PV)
|
Mycenax adheres to the three Process Validation (PV) stages from the latest regulator guidances, starting with a product-specific master plan. The stages include Process Design (PD, Stage 1), Process Performance Qualification (PPQ, Stage 2), and Continued Process Verification (CPV, Stage 3), covering all process performance metrics. This strategy is based on Quality by Design (QbD) principles and incorporates risk-based control to enhance lifecycle knowledge and continuous improvement, serving as Mycenax's guiding principles for consistent manufacturing performance. |
|||||
|
Service Highlights |
|||||
![]() |
![]() |
![]() |
||||
| Regulatory Inspections Experience | Global Quality System | PC & PV Expertise | ||||
| Successfully passed EMA, MHRA, PMDA, Health Canada and MFDS GMP inspections. | 120+ regulatory inspections and client audits globally. | Over 10 years of proven experience delivering customized solutions to meet client goals. |
|
Three-stage Process Validation Strategy to Accelerate Your Drug to Market |
|||||
![]() |
![]() |
CH-Aligned Process Characterization & Validation | |||
| Our PC/PV approach follows key ICH guidance (Q8–Q11), ensuring scientific understanding, risk-based control strategies, and robust process demonstration for regulatory compliance and commercial readiness. | ||||
|
Mycenax adheres to the three Process Validation (PV) stages from the latest regulator guidances, starting with a product-specific master plan. The stages include Process Design (PD, Stage 1), Process Performance Qualification (PPQ, Stage 2), and Continued Process Verification (CPV, Stage 3), covering all process performance metrics. This strategy is based on Quality by Design (QbD) principles and incorporates risk-based control to enhance lifecycle knowledge and continuous improvement, serving as Mycenax's guiding principles for consistent manufacturing performance. |
|||||
|
Service Highlights |
|||||
![]() |
|||||
|
Regulatory Inspections Experience |
|||||
|
Successfully passed EMA, MHRA, PMDA, Health Canada and MFDS GMP inspections. |
|||||
![]() |
|||||
|
Global Quality System |
|||||
|
120+ regulatory inspections and client audits globally. |
|||||
![]() |
|||||
|
PC & PV Expertise |
|||||
|
Over 10 years of proven experience delivering customized solutions to meet client goals. |
|||||
|
Three-stage Process Validation Strategy to Accelerate Your Drug to Market |
|||||
![]() |
|||||
![]() |
|||||
![]() |
|||||
![]() |
|
|
CH-Aligned Process Characterization & Validation |
|
|
Our PC/PV approach follows key ICH guidance (Q8–Q11), ensuring scientific understanding, risk-based control strategies, and robust process demonstration for regulatory compliance and commercial readiness. |
|























